Glycomet GP 3/850 Tablet SR Information
Glycomet GP 3/850 Tablet SR is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Diabetes. Glycomet GP 3/850 Tablet SR also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Glycomet GP 3/850 Tablet SR. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Common side effects of Glycomet GP 3/850 Tablet SR include Headache, Nausea or vomiting, Dizziness. Besides the aforementioned side effects, there are other adverse effects of Glycomet GP 3/850 Tablet SR as well, which are listed below. Such side effects of Glycomet GP 3/850 Tablet SR normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Glycomet GP 3/850 Tablet SR has a Unknown effect for pregnant women and Safe effect on lactating mothers. Warnings related to Glycomet GP 3/850 Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Heart Disease, Kidney Disease, Liver Disease must refrain from the use of Glycomet GP 3/850 Tablet SR since this can cause severe adverse effects. The section on Glycomet GP 3/850 Tablet SR contraindications lists all such conditions.
Besides this, Glycomet GP 3/850 Tablet SR may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Glycomet GP 3/850 Tablet SR is not safe while driving, and is not addiction.
Glycomet GP 3/850 Tablet SR Benefits & Uses
Glycomet GP 3/850 Tablet SR is used to treat the following -
Main Benefits
- Diabetes (Read More - 10 Home Remedies for Diabetes)
Other Benefits
- Diabetes Type 2
Glycomet GP 3/850 Tablet SR Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Glycomet GP 3/850 Tablet SR Related Warnings
-
Is the use of Glycomet GP 3/850 Tablet SR safe for pregnant women?
No research has been done to ascertain the safety of Glycomet GP in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Unknown -
Is the use of Glycomet GP 3/850 Tablet SR safe during breastfeeding?
Glycomet GP does not show any side effects in breastfeeding women.
Safe -
What is the effect of Glycomet GP 3/850 Tablet SR on the Kidneys?
Kidney can be affected by Glycomet GP. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
Moderate -
What is the effect of Glycomet GP 3/850 Tablet SR on the Liver?
Glycomet GP can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Moderate -
What is the effect of Glycomet GP 3/850 Tablet SR on the Heart?
Glycomet GP has very mild side effects on the heart.
Mild
Glycomet GP 3/850 Tablet SR Contraindications
If you are suffering from any of the following diseases, you should not take Glycomet GP 3/850 Tablet SR unless your doctor advises you to do so -
- Heart Disease
- Kidney Disease
- Liver Disease
- Anemia
Frequently asked Questions about Glycomet GP 3/850 Tablet SR
-
Is this Glycomet GP 3/850 Tablet SR habit forming or addictive?
Glycomet GP 3/850 Tablet SR does not cause addiction.
No -
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Glycomet GP 3/850 Tablet SR. So it is best to avoid driving.
Dangerous -
Is it safe?
Glycomet GP 3/850 Tablet SR is safe but it is important to consult a doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Glycomet GP 3/850 Tablet SR cannot treat any kind of mental disorder.
No
Glycomet GP 3/850 Tablet SR Interactions with Food and Alcohol
-
Interaction between Food and Glycomet GP 3/850 Tablet SR
Information is not available on the interaction of any foods with Glycomet GP 3/850 Tablet SR, due to a lack of research on this.
Unknown -
Interaction between Alcohol and Glycomet GP 3/850 Tablet SR
Due to lack of research, there is no information about the side effects of taking Glycomet GP 3/850 Tablet SR with alcohol.
Unknown
See all substitutes for Glycomet Gp
- Azulix 2 MF Forte Tablet PR - ₹237
- Gluconorm G2 Tablet PR - ₹274
- Gluconorm G1 Forte Tablet PR - ₹202
- Glycomet GP 1 Tablet PR - ₹115
- Gluconorm G 0.5 Tablet PR - ₹85
- Gluconorm G3 Forte Tablet - ₹258
- Glimestar M 4 Forte Tablet PR (10) - ₹123
- Gluconorm G4 Tablet PR - ₹271
- Gluconorm G2 Forte Tablet PR - ₹237
- Azulix 3 MF Tablet PR - ₹97
- Azulix 2 MF Tablet PR - ₹198
- Azulix 1 MF Tablet PR - ₹157
- Azulix 4 MF Tablet PR - ₹138
- Azulix 4 MF Forte Tablet PR - ₹167
- Glycomet GP 2/850 Tablet SR - ₹96
- Gluconorm G1 Tablet PR - ₹194
- Glycomet GP 2 Tablet PR - ₹169
- Azulix 1 MF Forte Tablet PR - ₹169
- Gluconorm G Plus 3 Tablet PR - ₹207
- Glimy M 2 Tablet PR - ₹227
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826